Peiyu Cheng
Overview
Explore the profile of Peiyu Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu Z, Wu Y, Cao Y, Cheng P
Front Oncol
. 2025 Mar;
15:1539417.
PMID: 40034600
Background: Lip and oral cavity cancer (LOC) is one of the common malignant tumors of the head and neck, posing significant health and economic burdens. The BRICS, including Brazil, Russia,...
2.
Yang Z, Li H, Chen L, Li S, Chen D, Lu T, et al.
Integr Cancer Ther
. 2025 Jan;
24:15347354241313334.
PMID: 39882758
Background: The prevalence of brain metastases (BM) in lung cancer patients is notably high and is associated with poor prognoses. The efficacy of standard treatment regimens in improving intracranial progression-free...
3.
Cheng F, Cheng P, Xie S, Wang H, Tang Y, Liu Y, et al.
BMC Public Health
. 2025 Jan;
25(1):137.
PMID: 39806358
Background: Ischemic stroke, accounting for 85% of stroke cases, leads to severe disabilities and increased mortality. Its global incidence rose by 87.55% from 1990 to 2019, posing significant health and...
4.
Zhang L, Cheng P, Du Y, Wang Q
Nanotechnology
. 2024 Dec;
36(9).
PMID: 39652895
Molybdenum disulfide (MoS) possesses excellent potential for applications in the field of optoelectronic detection. However, the atomic-level thickness of the monolayer MoSleads to weak light absorption and a restricted absorption...
5.
Wang X, Cheng F, Fu Q, Cheng P, Zuo J, Wu Y
BMC Pregnancy Childbirth
. 2024 Nov;
24(1):731.
PMID: 39516729
Objectives: Maternal hypertensive disorder (MHD) is a leading cause of significant maternal and fetal mortality and morbidity. The BRICS nations are crucial in the global MHD landscape, given their large...
6.
Yu Z, Ma X, Xiao H, Chen Y, Wu Y, He J, et al.
Front Public Health
. 2024 Sep;
12:1419428.
PMID: 39310910
Aims: This study addresses the essential need for updated information on the burden of lip and oral cavity cancer (LOC) in China for informed healthcare planning. We aim to estimate...
7.
Ai S, Gao Q, Cheng G, Zhong P, Cheng P, Ren Y, et al.
Biomacromolecules
. 2024 Mar;
25(3):2052-2064.
PMID: 38426456
Conventional embolists disreputably tend to recanalization arising from the low filling ratio due to their rigidity or instability. As a result, intelligent hydrogels with a tunable modulus may meaningfully improve...
8.
Yang Z, Li H, Dong T, Li G, Chen D, Li S, et al.
J Cancer Res Clin Oncol
. 2023 Aug;
149(15):13773-13792.
PMID: 37532906
Purpose: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the first-line therapy for patients with lung adenocarcinoma (LUAD) harboring activating EGFR mutations. However, the emergence of drug resistance to EGFR-TKIs...
9.
Ma F, Zhang H, Li B, Yang D, Cheng P, Yu M, et al.
Evid Based Complement Alternat Med
. 2023 Jan;
2023:7448034.
PMID: 36714533
Objective: The aim of this study is to evaluate the efficacy and safety of traditional Chinese medicine (TCM) for postviral olfactory dysfunction (PVOD). Methods: PubMed, EMBASE, Cochrane Central Register of...
10.
Li G, Ma Y, Yu M, Li X, Chen X, Gao Y, et al.
J Cancer
. 2021 Aug;
12(17):5286-5295.
PMID: 34335945
Targeting EGFR, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), brings lights to the treatment of non-small cell lung cancer (NSCLC). Although T790M mutation responded as one of the...